{"created":"2023-05-15T16:32:54.477843+00:00","id":4934,"links":{},"metadata":{"_buckets":{"deposit":"37121a8d-e23b-4b09-82f3-5392a7f8a504"},"_deposit":{"created_by":2,"id":"4934","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"4934"},"status":"published"},"_oai":{"id":"oai:nagasaki-u.repo.nii.ac.jp:00004934","sets":["8:9"]},"author_link":["20145","20141","20144","20140","20142","20138","20139","20148","20137","20146","20143","20147"],"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2015-11-04","bibliographicIssueDateType":"Issued"},"bibliographicPageStart":"335","bibliographicVolumeNumber":"16","bibliographic_titles":[{"bibliographic_title":"BMC Musculoskeletal Disorders"}]}]},"item_2_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Background: The aim of the study was to reassess the prevalence and characteristics of human T lymphotropic virus type I (HTLV-I)-associated Sjogren's syndrome (SS) and SS in HTLV-I-associated myelopathy (HAM) based on the American European Consensus Group (AECG) criteria in HTLV-I endemic area, Nagasaki prefecture. Methods: The 349 patients who underwent a minor salivary gland biopsy (MSGB) for suspected SS were retrospectively classified by AECG classification criteria and divided with or without anti-HTLV-I antibody. Results: The HTLV-I data-available 294 patients were investigated. One hundred-seventy patients were classified as SS and 26.5 % were HTLV-I-seropositive. We have included 26 patients with HTLV-I-associated myelopathy (HAM) and 38.5 % were classified as having SS. The prevalences of ANA and anti-SS-A/Ro antibody of HAM + SS were significantly low compared to the HTLV-I asymptomatic carriers (AC) with SS and the HTLV-I-seronegative SS patients, although lacrimal dysfunction tended to be high in HAM + SS and significantly high in AC + SS patients compared with the patients with HTLV-I-seronegative SS. The focus scores of MSGB in the HAM + SS patients were similar to those of the AC + SS patients and the HTLV-I-seronegative patients with SS. Among the MSGB-positive patients, there was a low prevalence of ANA in the HAM + SS patients. Similar results were obtained in case of anti-SS-A/Ro or SS-B/La antibody. Conclusion: In HTLV-I endemic area, high prevalence of anti-HTLV-I antibody among SS as well as the characteristics of HAM + SS and AC + SS was still determined by AECG classification criteria.","subitem_description_type":"Abstract"}]},"item_2_description_63":{"attribute_name":"引用","attribute_value_mlt":[{"subitem_description":"BMC Musculoskeletal Disorders, 16, 335; 2015","subitem_description_type":"Other"}]},"item_2_publisher_33":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"BioMed Central"}]},"item_2_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1186/s12891-015-0773-1","subitem_relation_type_select":"DOI"}}]},"item_2_rights_13":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"c Nakamura et al. 2015"},{"subitem_rights":"This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://?creativecommons.?org/?licenses/?by/?4.?0/?), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://?creativecommons.?org/?publicdomain/?zero/?1.?0/?) applies to the data made available in this article, unless otherwise stated."}]},"item_2_source_id_8":{"attribute_name":"EISSN","attribute_value_mlt":[{"subitem_source_identifier":"14712474","subitem_source_identifier_type":"ISSN"}]},"item_2_version_type_16":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Nakamura, Hideki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Shimizu, Toshimasa"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Takagi, Yukinori"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Takahashi, Yoshiko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Horai, Yoshiro"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Nakashima, Yoshikazu"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sato, Shuntaro"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Shiraishi, Hirokazu"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Nakamura, Tatsufumi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Fukuoka, Junya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Nakamura, Takashi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Kawakami, Atsushi"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-12-21"}],"displaytype":"detail","filename":"BMCMD16_335.pdf","filesize":[{"value":"857.6 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"BMCMD16_335.pdf","url":"https://nagasaki-u.repo.nii.ac.jp/record/4934/files/BMCMD16_335.pdf"},"version_id":"255ddf2a-4b95-469d-b32f-d84f70232d5e"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"AECG criteria","subitem_subject_scheme":"Other"},{"subitem_subject":"HTLV-I","subitem_subject_scheme":"Other"},{"subitem_subject":"Minor salivary gland biopsy","subitem_subject_scheme":"Other"},{"subitem_subject":"Sjogren's syndrome","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjogren’s syndrome","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjogren’s syndrome"}]},"item_type_id":"2","owner":"2","path":["9"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-12-21"},"publish_date":"2015-12-21","publish_status":"0","recid":"4934","relation_version_is_last":true,"title":["Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjogren’s syndrome"],"weko_creator_id":"2","weko_shared_id":-1},"updated":"2023-05-16T03:14:13.079682+00:00"}